Liz Critaholo
Vice President of Investor Relations, Tempest
Replay available
Tempus AI, Inc. (NASDAQ: TEM) Q2 2025 earnings conference call, held 2025-08-08. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations, Tempest
Founder and Chief Executive Officer, Tempest
Chief Financial Officer, Tempest
Analyst, TD Cowen
Analyst, Morgan Stanley
Analyst, JPMorgan
Analyst, Bank of America
Analyst, Needham & Company
Analyst, Stifel
Analyst, DTIG
Analyst, William Lear
Analyst, Wolfe Research
Analyst, Guggenheim Securities
plays on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. I'll now turn the conference over to Liz Critaholo, VP of Investor Relations. You may begin. Thank you. Good morning and welcome to Tempest's second quarter 2025 conference call. This morning, Tempest released results for the quarter ended June 30th, 2025. The press release, an overview of the quarter, and our latest presentation are available on our IR website. Joining me today from Tempest are Eric Lepkovsky, founder and CEO of Tempest, and Ben Rodgers, CFO. Before we begin, I would like to remind you that during this call, management may make forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially. For discussion of these risks, please refer to our 10-K and other subsequent filings with the SEC. During the call, we will discuss non-GAAP financial measures, which are not prepared in accordance with generally accepted accounting principles. Definitions of these non-GAAP financial measures, along with reconciliations to the most directly comparable GAAP financial measures, are included in our earnings release, which has been furnished to the SEC and is available on our website at investors.temphis.com. I would now like to turn the call over to Eric. Good morning, everyone. So I'll provide a quick summary. U2 is a fantastic quarter. As I mentioned in my letter, the company is hitting its stride as we approach our 10th anniversary, which is great. Revenue increased 89.6% to $314.6 million. Genomics revenue increased 115% to $241.8 million. On accelerating volum...